RecruitingPhase 2Phase 3NCT06785337

"The Effect of Inhaled Nitroglycerin for COPD Patients

"The Effect of Inhaled Nitroglycerin on Improving Respiratory Failure in COPD Patients Admitted to Adult Intensive Care Unit"

Sponsor

Beni-Suef University

Enrollment

40 participants

Start Date

Feb 1, 2025

Study Type

INTERVENTIONAL

Conditions

COPD COPD III/IV

Summary

this study aims to investigative the benefits of using nebulized nitroglycerin in improving respiratory functions in patients of late stage COPD

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether inhaled nitroglycerin — a drug that relaxes blood vessels — can help relieve high blood pressure in the lungs (pulmonary hypertension) in COPD patients who are in respiratory failure. By inhaling the drug, it may reach the lungs more directly than other routes. **You may be eligible if...** - You are 18 or older - You have COPD and are currently having a flare-up with respiratory failure - An echocardiogram (heart ultrasound) has shown you have pulmonary hypertension (high pressure in the lung arteries) **You may NOT be eligible if...** - You have severe left heart failure - You are pregnant - You are allergic to nitroglycerin Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.